| Full text | |
| Author(s): Show less - |
Harris, Meredith G.
[1, 2]
;
Kazdin, Alan E.
[3]
;
Chiu, Wai Tat
[4]
;
Sampson, Nancy A.
[4]
;
Aguilar-Gaxiola, Sergio
[5]
;
Al-Hamzawi, Ali
[6]
;
Alonso, Jordi
[7, 8, 9]
;
Altwaijri, Yasmin
[10]
;
Andrade, Laura Helena
[11]
;
Cardoso, Graca
[12, 13]
;
Cia, Alfredo
[14]
;
Florescu, Silvia
[15]
;
Gureje, Oye
[16]
;
Hu, Chiyi
[17]
;
Karam, Elie G.
[18, 19, 20]
;
Karam, Georges
[18, 19, 20]
;
Mneimneh, Zeina
[21]
;
Navarro-Mateu, Fernando
[22]
;
Oladeji, Bibilola D.
[16]
;
O'Neill, Siobhan
[23]
;
Scott, Kate
[24]
;
Slade, Tim
[25]
;
Torres, Yolanda
[26]
;
Vigo, Daniel
[27, 28]
;
Wojtyniak, Bogdan
[29]
;
Zarkov, Zahari
[30]
;
Ziv, Yuval
[31]
;
Kessler, Ronald C.
[4]
;
Hlth, WHO World Mental
Total Authors: 29
|
| Affiliation: Show less - | [1] Univ Queensland, Sch Publ Hlth, Herston, Qld - Australia
[2] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Wacol, Qld - Australia
[3] Yale Univ, Dept Psychol, New Haven, CT - USA
[4] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 - USA
[5] UC Davis Hlth Syst, Ctr Reducing Hlth Dispar, Sacramento, CA - USA
[6] Al Qadisiya Univ, Coll Med, Diwaniya Governorate - Iraq
[7] CIBER Epidemiol & Salud Publ, Barcelona - Spain
[8] Pompeu Fabra Univ, Dept Ciencies Expt & Salut, Barcelona - Spain
[9] Parc Salut Mar, IMIM Hosp del Mar Res Inst, Barcelona - Spain
[10] King Faisal Specialist Hosp & Res Ctr, Epidemiol Sect, Riyadh - Saudi Arabia
[11] Univ Sao Paulo, Fac Med, Hosp Clin, Nucleo Epidemiol Psiquiatr LIM 23, Inst Psiquiatri, Sao Paulo - Brazil
[12] NOVA Univ Lisbon, NOVA Med Sch, Lisbon Inst Global Mental Hlth, Lisbon - Portugal
[13] NOVA Univ Lisbon, NOVA Med Sch, Chron Dis Res Ctr, Lisbon - Portugal
[14] Anxiety Disorders Ctr, Buenos Aires, DF - Argentina
[15] Natl Sch Publ Hlth Management & Dev, Bucharest - Romania
[16] Univ Coll Hosp, Dept Psychiat, Ibadan - Nigeria
[17] Shenzhen Kangning Hosp, Shenzhen Inst Mental Hlth, Shenzhen - Peoples R China
[18] Inst Dev Res Advocacy & Appl Care, Beirut - Lebanon
[19] Balamand Univ, Dept Psychiat & Clin Psychol, Fac Med, Beirut - Lebanon
[20] St George Hosp Univ, Dept Psychiat & Clin Psychol, Med Ctr, Beirut - Lebanon
[21] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI - USA
[22] CIBERESP Murcia, IMIB Arrixaca, Serv Murciano Salud, UDIF SM, Subdirecc Gen Planificac Innovac & Cronic, Murcia - Spain
[23] Ulster Univ, Sch Psychol, Coleraine, Londonderry - North Ireland
[24] Univ Otago, Dept Psychol Med, Dunedin, Otago - New Zealand
[25] Univ Sydney, Matilda Ctr Res Mental Hlth & Subst Use, Sydney, NSW - Australia
[26] CES Univ, Ctr Excellence Res Mental Hlth, Medellin - Colombia
[27] Univ British Columbia, Dept Psychiat, Vancouver, BC - Canada
[28] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 - USA
[29] Natl Inst Hyg, Natl Inst Publ Hlth, Warsaw - Poland
[30] Directorate Mental Hlth & Prevent Addict, Natl Ctr Publ Hlth & Anal, Sofia - Bulgaria
[31] Israeli Minist Hlth, Mental Hlth Serv, Jerusalem - Israel
Total Affiliations: 31
|
| Document type: | Journal article |
| Source: | JAMA PSYCHIATRY; v. 77, n. 8, p. 830-841, AUG 2020. |
| Web of Science Citations: | 1 |
| Abstract | |
Key PointsQuestionWhat proportion of patients with depression perceive treatment as helpful? FindingsThis study of 80332 respondents surveyed in 16 countries found that 68.2% of adults with a lifetime history of DSM-IV major depressive disorder (n=2726) obtained treatment that they considered helpful; other patients stopped seeking treatment after early unhelpful treatment. Most patients (93.9%) were helped if they persisted through 10 treatment professionals, but only 21.5% of patients were that persistent. MeaningMany more patients with major depressive disorder might obtain helpful treatment if they persist after early unhelpful treatment. ImportanceThe perceived helpfulness of treatment is an important patient-centered measure that is a joint function of whether treatment professionals are perceived as helpful and whether patients persist in help-seeking after previous unhelpful treatments. ObjectiveTo examine the prevalence and factors associated with the 2 main components of perceived helpfulness of treatment in a representative sample of individuals with a lifetime history of DSM-IV major depressive disorder (MDD). Design, Setting, and ParticipantsThis study examined the results of a coordinated series of community epidemiologic surveys of noninstitutionalized adults using the World Health Organization World Mental Health surveys. Seventeen surveys were conducted in 16 countries (8 surveys in high-income countries and 9 in low- and middle-income countries). The dates of data collection ranged from 2002 to 2003 (Lebanon) to 2016 to 2017 (Bulgaria). Participants included those with a lifetime history of treated MDD. Data analyses were conducted from April 2019 to January 2020. Data on socioeconomic characteristics, lifetime comorbid conditions (eg, anxiety and substance use disorders), treatment type, treatment timing, and country income level were collected. Main Outcomes and MeasuresConditional probabilities of helpful treatment after seeing between 1 and 5 professionals; persistence in help-seeking after between 1 and 4 unhelpful treatments; and ever obtaining helpful treatment regardless of number of professionals seen. ResultsSurvey response rates ranged from 50.4% (Poland) to 97.2% (Medellin, Columbia), with a pooled response rate of 68.3% (n=117616) across surveys. Mean (SE) age at first depression treatment was 34.8 (0.3) years, and 69.4% were female. Of 2726 people with a lifetime history of treatment of MDD, the cumulative probability (SE) of all respondents pooled across countries of helpful treatment after seeing up to 10 professionals was 93.9% (1.2%), but only 21.5% (3.2%) of patients persisted that long (ie, beyond 9 unhelpful treatments), resulting in 68.2% (1.1%) of patients ever receiving treatment that they perceived as helpful. The probability of perceiving treatment as helpful increased in association with 4 factors: older age at initiating treatment (adjusted odds ratio {[}AOR], 1.02; 95% CI, 1.01-1.03), higher educational level (low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), shorter delay in initiating treatment after first onset (AOR, 0.98; 95% CI, 0.97-0.99), and medication received from a mental health specialist (AOR, 2.91; 95% CI, 2.04-4.15). Decomposition analysis showed that the first 2 of these 4 factors were associated with only the conditional probability of an individual treatment professional being perceived as helpful (age at first depression treatment: AOR, 1.02; 95% CI, 1.01-1.02; educational level: low: AOR, 0.48; 95% CI, 0.33-0.70; low-average: AOR, 0.62; 95% CI, 0.44-0.89; high-average: AOR, 0.67; 95% CI, 0.49-0.91 vs high educational level), whereas the latter 2 factors were associated with only persistence (treatment delay: AOR, 0.98; 95% CI, 0.97-0.99; treatment type: AOR, 3.43; 95% CI, 2.51-4.70). Conclusions and RelevanceThe probability that patients with MDD obtain treatment that they consider helpful might increase, perhaps markedly, if they persisted in help-seeking after unhelpful treatments with up to 9 prior professionals. This study analyzes surveys conducted in 16 countries to evaluate the proportion of respondents with a lifetime history of major depressive disorder who perceive treatment professionals as helpful and who persist in help-seeking after previous unhelpful treatments. (AU) | |
| FAPESP's process: | 16/50307-3 - Mental health, migration and the megacity (São Paulo) - M3SP |
| Grantee: | Laura Helena Silveira Guerra de Andrade |
| Support Opportunities: | Regular Research Grants |
| FAPESP's process: | 03/00204-3 - Epidemiological study of psychiatric disorders in the São Paulo Metropolitan Region: prevalence, risk factors, and social and economical burden |
| Grantee: | Laura Helena Silveira Guerra de Andrade |
| Support Opportunities: | Research Projects - Thematic Grants |